Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

British American Tobacco Ups Its Organigram Stake; Curaleaf Slips On Rumors

By Investing.com (Brenda O'Farrell/Investing.com)Stock MarketsMar 08, 2022 08:35AM ET
www.investing.com/analysis/british-american-tobacco-ups-its-organigram-stake-curaleaf-slips-on-rumors-200619487
British American Tobacco Ups Its Organigram Stake; Curaleaf Slips On Rumors
By Investing.com (Brenda O'Farrell/Investing.com)   |  Mar 08, 2022 08:35AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 

One of the largest tobacco companies in the world increased its ownership position in a small Canadian cannabis company last week as part of a deal struck one year ago.

British American Tobacco (NYSE:BTI) invested an additional C$6.3 million ($4.9 million) in New Brunswick-based Organigram Holdings (NASDAQ:OGI) (TSX:OGI), upping its stake to 19.5% from 18.8%.

The move is part of the deal the two companies initiated in March 2021 that provides for periodic “top-up” investments following share issuances. Last December, Organigram issued 11 million shares to finance the acquisition of Laurentian Organic, a Quebec-based craft cannabis company. BAT purchased just over 2.6 million of those shares at an average price of $2.3868, according to a statement released by the companies.

The news gave shares of the Organigram, which specializes in recreational and medical cannabis offerings, a small boost. The stock jumped from a low two weeks ago of about $1.40 a share to about $1.50 a share on the news. But by the end of last week, Organigram closed at $1.38, down just over 2% on the day on Friday, and a drop of 1.4% since the announcement.

Organigram Weekly Chart.
Organigram Weekly Chart.

Yesterday, shares of Organigram closed at $1.31, down another 5% on the day. In the last 12 months, shares of the company have lost 48.5%.

The Cost Of War And Rumors

It’s been a tough few weeks for Curaleaf Holdings (OTC:CURLF). The US-based cannabis company made an unprecedented move—perhaps a reflection of the unprecedented times.

In a statement to investors the marijuana giant said:

“Curaleaf would like to provide some clarity by addressing speculation regarding how the Russia-Ukraine crisis may impact the company.”

It went on to explain:

“The speculation on social media that the Company and its major shareholders and executives will somehow be subject to any US government economic sanctions now or in the future is incorrect.”

The statement outlined specifics that included that the company’s executive chairman and largest shareholder, Boris Jordan, “is an American citizen, born and raised on Long Island, New York. He is not, and has never been, a citizen of any other country.”

And that the company’s second-largest shareholder, Andrei Blokh, “is a US citizen, who also holds a Russian passport.”

Blokh is reported to hold a 21% stake in the company.

The aim of the statement was to clearly state that the company’s executives and shareholders are not affected by the US government’s sanctions imposed on Russia.

Shares of Curaleaf have lost 26.8% since Feb. 24, the day Russian forces invaded Ukraine, dropping from $7.49 to $5.48 at yesterday’s close.

Curaleaf Weekly Chart.
Curaleaf Weekly Chart.

On Mar. 3, the Massachusetts-based Curaleaf presented its fourth quarter and year-end results that included two record line items. The company’s fiscal year 2021 set new revenue and adjusted EBITDA records of $1.2 billion and $298 million, respectively.

These figures represented gains of 93% for revenue and 107% for EBITDA.

British American Tobacco Ups Its Organigram Stake; Curaleaf Slips On Rumors
 

Related Articles

British American Tobacco Ups Its Organigram Stake; Curaleaf Slips On Rumors

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (3)
Sajjad Khoso
Sajjad Khoso Mar 10, 2022 11:53AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Mohd Izhar Muslim
Mohd Izhar Muslim Mar 09, 2022 2:55AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Lovely
Javed Afridi
Javed Afridi Mar 08, 2022 1:51PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
how work in this app
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email